Mouse models have generally failed to recapitulate the dopaminergic neurodegeneration seen in Parkinson's disease. Expressing mutant α-synuclein in a background of elevated dopamine generates mice with nigrostriatal degeneration.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability
npj Parkinson's Disease Open Access 18 August 2021
-
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Molecular Neurodegeneration Open Access 20 August 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
20 December 2017
In the version of this article initially published, the molecular mass of synuclein was given as 140 kDa instead of ∼14 kDa. The error has been corrected in the HTML and PDF versions of the article.
References
Mor, D.E. et al. Nat. Neurosci. 20, 1560–1568 (2017).
Graham, D.G. Mol. Pharmacol. 14, 633–643 (1978).
Hastings, T.G., Lewis, D.A. & Zigmond, M.J. Proc. Natl. Acad. Sci. USA 93, 1956–1961 (1996).
Conway, K.A., Rochet, J.C., Bieganski, R.M. & Lansbury, P.T. Jr. Science 294, 1346–1349 (2001).
Wang, L. et al. Curr. Biol. 24, 2319–2326 (2014).
Burré, J. et al. Science 329, 1663–1667 (2010).
Nemani, V.M. et al. Neuron 65, 66–79 (2010).
Vargas, K.J. et al. Cell Rep. 18, 161–173 (2017).
Busch, D.J. et al. Mol. Biol. Cell 25, 3926–3941 (2014).
Scott, D.A. et al. J. Neurosci. 30, 8083–8095 (2010).
Scott, D. & Roy, S. J. Neurosci. 32, 10129–10135 (2012).
Kirik, D. et al. Proc. Natl. Acad. Sci. USA 100, 2884–2889 (2003).
Kramer, M.L. & Schulz-Schaeffer, W.J. J. Neurosci. 27, 1405–1410 (2007).
Choi, B.K. et al. Proc. Natl. Acad. Sci. USA 110, 4087–4092 (2013).
Martinez-Vicente, M. et al. J. Clin. Invest. 118, 777–788 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Roy, S. Synuclein and dopamine: the Bonnie and Clyde of Parkinson's disease. Nat Neurosci 20, 1514–1515 (2017). https://doi.org/10.1038/nn.4660
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.4660
This article is cited by
-
α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability
npj Parkinson's Disease (2021)
-
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Molecular Neurodegeneration (2019)